Innoviva, Inc. (THRX)

Theseus Pharmaceuticals Revenue

Theseus Pharmaceuticals had revenue of $107.80M in the quarter ending September 30, 2025, with 20.44% growth. This brings the company's revenue in the last twelve months to $388.52M, up 10.14% year-over-year. In the year 2024, Theseus Pharmaceuticals had annual revenue of $358.71M with 15.54% growth.

• Revenue (ttm): $388.52M
• Revenue Growth: +10.14%
• P/S Ratio: 3.19
• Revenue / Employee: $2,824,496
• Employees: 127
• Market Cap: 1.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	358.71M	48.25M	15.54%
Dec 31, 2023	310.46M	-20.88M	-6.30%
Dec 31, 2022	331.34M	-60.53M	-15.45%
Dec 31, 2021	391.87M	55.07M	16.35%
Dec 31, 2020	336.79M	75.78M	29.03%
Dec 31, 2019	261.02M	12.00K	-
Dec 31, 2018	261.00M	43.79M	20.16%
Dec 31, 2017	217.22M	83.65M	62.63%
Dec 31, 2016	133.57M	79.62M	147.58%
Dec 31, 2015	53.95M	45.52M	539.74%
Dec 31, 2014	8.43M	3.90M	86.08%
Dec 31, 2013	4.53M	-1.08M	-19.26%
Dec 31, 2012	5.61M	-18.90M	-77.10%
Dec 31, 2011	24.51M	289.00K	1.19%
Dec 31, 2010	24.22M	-151.00K	-0.62%
Dec 31, 2009	24.37M	1.28M	5.53%
Dec 31, 2008	23.10M	1.09M	4.97%
Dec 31, 2007	22.00M	2.42M	12.33%
Dec 31, 2006	19.59M	7.53M	62.49%
Dec 31, 2005	12.05M	-	-